Modulation of mouse endotoxic fever by complement.
It was recently reported that the complement system may be critically involved in the febrile response of guinea pigs to systemic, particularly intraperitoneally (i.p.) injected, lipopolysaccharides (LPS). The present study was designed to identify which component(s) of the complement cascade may be specifically critical. To this end, we used mice with C3, C5, and CR2 gene deletions. To assess preliminarily the suitability of mice for such a study, we replicated our earlier studies with guinea pigs. Thus, to verify initially whether complement is similarly involved in the febrile response of wild-type (C57BL/6J) mice to i.p. LPS (Escherichia coli, 1 microg/mouse), we depleted complement with cobra venom factor (CVF; 7 U/mouse, intravenously [i.v.]). These animals did not develop fever, whereas the core temperature (T(c)) of CVF vehicle-treated controls rose approximately 1 degrees C by 80 min postinjection and then gradually abated over the following 2.5 h, confirming the involvement of complement in fever production after i.p. LPS injection and the suitability of this species for these studies. C3- and C5-sufficient (C3(+/+) and C5(+/+)) mice also developed 1 degrees C fevers within 80 min after i.p. LPS (1 or 2 microg/mouse) injection. These fevers were totally prevented by CVF (10 U/mouse, i.v.) pretreatment. C3- and C5-deficient (C3(-/-) and C5(-/-)) mice were also unable to develop T(c) rises after i.p. LPS. Both CR2(+/+) and CR2(-/-) mice responded normally to i.p. LPS (1 microg/mouse). These data indicate that C5, but not C3d acting through CR2, may play a critical role in the febrile response of mice to i.p. LPS.
Li
S
S
Department of Physiology, The University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Holers
V M
VM
Boackle
S A
SA
Blatteis
C M
CM
D000209:Acute-Phase Proteins; D000818:Animals; D002352:Carrier Proteins / Q000502:physiology; D003176:Complement C3 / Q000502:physiology; D003182:Complement C5 / Q000502:physiology; D003165:Complement System Proteins / Q000502:physiology*; D016207:Cytokines / Q000096:biosynthesis; D004546:Elapid Venoms / Q000494:pharmacology; D005334:Fever / Q000209:etiology*; D018950:Lipopolysaccharide Receptors / Q000502:physiology; D008070:Lipopolysaccharides / Q000633:toxicity*; D008562:Membrane Glycoproteins; D051379:Mice; D008810:Mice, Inbred C57BL; D017464:Receptors, Complement 3d / Q000502:physiology; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D003176:Complement C3; D003182:Complement C5; D003165:Complement System Proteins; D016207:Cytokines; D004546:Elapid Venoms; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D017464:Receptors, Complement 3d; D000099231:Lipopolysaccharide-Binding Protein; C016310:cobra venom factor